During galenic formulation development, homogeneity of distribution is a critical parameter to check since it may influence activity and safety of the drug. Raman hyperspectral imaging is a technique of choice for assessing the distributional homogeneity of compounds of interest. Indeed, the combination of both spectroscopic and spatial information provides a detailed knowledge of chemical composition and component distribution.
Introduction
During pharmaceutical development, assessment of the homogeneity of powder blends is a critical step that will impact both medicine safety and efficacy. Actually, HPLC is the commonly used technique consuming time and requiring a lot of resources. This is the reason why NIR and Raman spectroscopies have been more and more used to study powder blend processes [1] [2] [3] . However, none of these techniques can determine the spatial distribution of the components in the final product.
Hyperspectral imaging combines spectral and spatial information. Therefore, it has gained in importance in pharmaceutical analysis during the last decade. Indeed, it allows obtaining simultaneously the API (Active Pharmaceutical Ingredient) concentration and its corresponding distribution map [4] .
In the pharmaceutical field, hyperspectral techniques are mainly based on Raman, nearinfrared (NIR-CI) or mid-infrared (MIR-CI) spectroscopies and have been used to obtain quantitative distribution maps of pharmaceutical ingredients [5] [6] [7] , to detect and quantify polymorphs [8, 9] , to characterize particle size [10] , to detect counterfeit medicines [11] and to characterize blending conditions [12, 13] .
Several approaches have been used to assess the distributional homogeneity in an objective way. Most of them used a quantitative model to obtain distribution maps and then analyzed the histogram of pixel concentrations [14] [15] [16] [17] . Histograms parameters (mean, standard deviation, skewness and kurtosis) are useful to assess the "constitutional homogeneity" which is the dispersion of pixel concentration values [6] . However, two maps may have exactly the 4 same constitutional homogeneity while being spatially totally different. This is why it is also important to assess the distributional homogeneity.
Usually, distributional homogeneity is assessed by visual inspection of distribution maps.
This approach clearly lacks objectivity and if the difference between the two maps is tight, it is impossible to unequivocally declare which one is the most homogeneous.
Therefore, Rosas et al. [18] [19] [20] developed a criterion to obtain an objective value of distributional homogeneity. This criterion is based on the analysis of the Poole index of nonoverlapping macropixels. However, this approach has several limitations. As it works with non-overlapping macropixels, it is quickly limited for the analysis of small distribution maps.
Furthermore, studied map must be binarized. This binarization step is inevitably a source of error. Therefore, it appears that it could be advantageous to develop a new criterion which could analyze small maps and which would need as few input and pre-processing as possible to avoid as much error as possible.
In this paper, we describe a new criterion called Distributional Homogeneity Index (DHI).
This index can be performed on small maps with continuous values. Relevance of the developed DHI has been tested on simulated distribution maps of controlled increasing homogeneity.
Secondly, DHI has been applied on several developed formulations with different content uniformity values. As these formulations were under investigation, no quantitative model (e.g. partial least square model) should be built. DHI was then tested on distribution maps obtained by semi-quantitative methods.
Material and methods
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Samples
Several pilot blends of 8 kg were produced with different blending conditions, API particle size and excipients grade. Final concentration of API was of 8.4 % (w/w). These blends were then pressed in tablets of 80 mg and of 5 mm of diameter.
Tablets were collected in a stratified way (begin, middle and end of the tableting) for several blends. For each blend, begin, middle and end samples were considered as different batches.
Batch selection for hyperspectral analysis was performed choosing a specific blend and a specific tableting time. To do so, ten tablets per batch were randomly chosen, assayed by HPLC and the content uniformity (expressed as relative standard deviation, RSD %) and the European Pharmacopoeia's acceptance value [21] 
Instrumentation
Raman hyperspectral images were collected with a dispersive Raman spectrometer RamanStation 400F (Perkin Elmer, MA, USA) equipped with a two-dimensional CCD detector (1024 × 256 pixel sensor). The laser excitation wavelength used was 785 nm with a power of 100 mW.
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The measured spectral region was 1622-90 cm -1 and the spectral resolution was equal to 2 cm −1 . One accumulation with a 1 second exposure time was performed per sample mapping point. The distance between 2 consecutives mapping measurements was fixed at 100 µm.
Background acquisition during mapping was repeated each 20 minutes. The spectra were collected with the Spectrum 6.3.2.0151 (Perkin Elmer) software.
The analyzed tablet surface was prepared beforehand with a Leica EM Rapid milling system equipped with a tungsten carbide miller (Leica Microsystems GmbH, Wetzlar, Germany).
Tablets were circular with a diameter of 6 mm (area of 28 mm²). Measured maps represented the greatest square possible with a map size of 40x40 and a step size of 100 µm. A total surface of 16 mm² was covered.
Ten tablets per batch were analyzed.
Data processing
Once acquired, the hyperspectral images underwent preprocessing and multivariate analysis to extract useful information.
First, hyperspectral data cubes ( × × ) were unfolded into a two-dimensional array ( × ) where and are the spatial information and λ the spectral information. Once unfolded, Raman spectra were baseline corrected using the Asymmetric Least Squares (AsLS)
algorithm [22] with a λ value of 10 5 and a p value of 0.001.
Then, cosmic rays have been removed using the algorithm developed by Sabin et al. [23] with a parameter k set at 15.
Two multivariate data analysis approaches were used:
7 Classical Least Squares (CLS) regression: Distribution maps were obtained using CLS regression. This method assumes that Beer-Lambert's law is respected and that the sum of the individual absorbance for each component equals the total absorbance for each pixel.
Therefore, it computes the concentration of each component by direct regression of the hyperspectral data cube by using the pure spectra.
It is a very easy and fast method but it is not flexible at all and any variability not reflected in the pure spectrum may affect the results [24] . Therefore, to obtain pure spectra as representative as possible, they have been resolved with Multivariate Curve Resolution -
Alternating Least Squares (MCR-ALS).
All analyzed maps were assembled and one every tenth spectrum was retained. Then, resolution of the pure spectra of each component was performed by the MCR-ALS toolbox [25] [26] [27] . Initial spectra estimates were obtained by simple-to-use-interactive self-modelling mixture analysis (SIMPLISMA) [28] . The constraints applied in the resolution analysis were non-negativity in the concentration profiles and spectra.
The advantage of image multiset analysis by MCR-ALS is the higher robustness of the resolved spectra and concentration maps.
Refolded CLS scores of the API were then used as distribution map.
Principal Component Analysis (PCA): PCA is a variable reduction technique, which reduces the number of variables by making linear combinations of the original variables. These combinations are called the principal components (PC) and are defined in such way that they explain the highest (remaining) variability in the data and are by definition orthogonal.
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The importance of the original variables in the definition of a principal component is represented by its loadings and the projections of the objects onto the principal components are called the scores of the objects [29] .
Unfolded preprocessed data cubes were mean centered before PCA analysis. The first PC was linked to the API with a good confidence since the correlation coefficient between the first loading and the pure API spectrum is higher than 0.966 (see supplementary Table S3 ).
However, such a strategy is only applicable if a sufficient proof of correlation between the loading and the studied compound is obtained. Refolded scores of the first PC were then used as distribution map of the API.
DHI and preprocessing of hyperspectral data cubes were performed using routines written in Matlab R2013a (The Mathworks, Natick, MA, USA). Multivariate data analysis was performed using the PLS_Toolbox 7.0.3 (Wenatchee, WA, USA) running on Matlab and MCR-ALS was performed using the toolbox described in [27] .
Analysis of experimental data was performed on Microsoft Excel 2010 (Microsoft, Albuquerque, NM, USA).
Results and discussion
Distributional Homogeneity Index (DHI)
As stated before, conventional homogeneity testing of distribution maps consists of analyzing [30] . A macropixel is a "square cluster of neighboring pixels with an intensity value equal to the average value of the included pixels". Macropixel size can vary from a single pixel size to the entire distribution map size.
The distribution map is first sampled by all possible macropixel of size 2x2 original pixel size. Then, all macropixels of size 3x3 are evaluated. The computation goes on with unit macropixel size increase until macropixel size equals the whole distribution map size. This approach is called the Continuous-Level Moving Block (CLMB) [30] . Therefore, for a defined macropixel size, there exists a total number of macropixels of (image sizemacropixel size +1)².
For each macropixel size, the standard deviation of the macropixel value is computed. Then, standard deviation is plotted against the macropixel size to obtain the so-called "homogeneity curve" [31] .
Once the homogeneity curve obtained for the studied distribution map, the map is randomized and the homogeneity curve of the random map is computed. DHI value is obtained by the ratio of the area under the homogeneity curve (AUC) of the studied map and the area under the homogeneity curve of the randomized map ( Figure 1 ).
Because of the randomization step, many simulations are necessary (generally 50 to 100 simulations) to compute a mean DHI value assorted with a standard deviation value.
It is now obvious that DHI is rather an inhomogeneity index than a homogeneity index as its value increases as the homogeneity of the distribution map decreases. 
Test of DHI with controlled homogeneity maps
In order to test the properties of DHI and to evaluate the relationship between DHI and distribution map homogeneity, controlled homogeneity maps were constructed. These maps Indeed, a 100 % controlled homogeneity map means that each half has 50 % of zeros and 50 % of pseudorandom values randomly mixed.
Such simulated maps mimic well distribution maps and allow testing DHI on continuous values maps. Indeed, in the method developed by Rosas et al. [18] [19] [20] , distribution maps are binarized prior to homogeneity evaluation. However, the threshold selection to achieve this binarization remains a non-trivial task and can therefore greatly affect the homogeneity measured. It appeared to us that the opportunity to work with continuous values maps could greatly ease the analysis.
Controlled homogeneity maps of different sizes were built with homogeneity ranging from 90 % to 10 %. Extreme homogeneity situations of 0 % and 100 % were avoided due to their unreal character that could mislead us in our conclusions. These maps were simulated four times and the DHI were computed.
As one can see on Figure 2b 
b) Plot showing the relationship between DHI values and the controlled homogeneity of the simulated distribution maps of size 40x40 (red circles), 60x60 (blue triangles), 100x100 (green diamond-shaped), 140x140 (turquoise crosses) and 160x160 (violet squares). Each controlled homogeneity map has been simulated four times. Best fit linear relationship was drawn with the four computed DHI values. Equation and coefficient of determination of corresponding best fit lines are
shown.
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Analysis of real samples
As DHI represents spatial heterogeneity in API distribution, it has been decided to validate it with the well-known content uniformity test. The main idea was to develop a non-destructive and ecological friendly test that could be used by pharmaceutical industry while developing new formulations. Once prepared (milled), tablet are not destroyed by hyperspectral imaging and could therefore stay in a sample bank for further analysis or even inspections.
During formulation development, five batches of tablets were produced with content uniformity ranging from 0.46 % to 11.04 %. These batches represent well the variability that can be encountered during formulation development: different API particle size, excipient grades and blending conditions.
Once obtained, the hyperspectral images were processed and the distribution maps were obtained by CLS or PCA analysis (see section 2.3). DHI were computed on distribution maps obtained by the two methods. Another interesting observation is that DHI values measured from distribution maps obtained by both CLS and PCA are comparable (Table 1) .
These observations constitute a major advantage of the DHI methodology since it is now possible to determine which formulation is the more homogeneous with neither any calibration dataset nor wet chemistry step. Indeed, multivariate calibration is difficult to implement since it necessitates the production of calibration samples with different nominal concentrations. Furthermore, any change in formulation leads to a complete re-development of the calibration model which is clearly not possible during formulation development step.
Hyperspectral imaging enables a fast analysis of different formulations while keeping prepared samples in a sample bank for any further analysis. 
Conclusion
A new methodology for the assessment of spatial homogeneity in hyperspectral images has been presented. This methodology called Distributional Homogeneity Index (DHI) is based on the ratio of the area under the curve of the homogeneity curve of the raw studied map and the area under the curve of the homogeneity curve of the randomized studied map.
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The DHI have been tested on simulated maps of increasing controlled homogeneity mimicking distribution maps of the studied compound. A linear relationship has been found between DHI values and controlled homogeneity. It has also been demonstrated that DHI values were dependent of map size. Therefore, to be compared, two tablets must be analyzed with the same parameters.
Simulated maps of the same size but with different proportions of zeros were tested. DHI values were, as presumed, dependent of the proportion of zeros. Therefore, two blend mixtures with very different proportions of the studied compound must be compared cautiously.
Nevertheless, it has been shown that DHI is a useful methodology to compare the distribution homogeneity of different blend mixtures during formulation development. This comparison is possible with distribution maps obtained without any calibration by CLS or PCA which lightens substantially the analysis work and enables a fast and non-destructive analysis of the samples.
The DHI approach has been tested on real samples of different pilot batches during formulation development. Linear relationship has been observed between DHI values and content uniformity values and with European Pharmacopoeia's acceptance values of the different batches allowing the selection of the most homogeneous formulation.
As with any application of hyperspectral imaging, sampling aspects are very important. This is why laser spot size, the spatial resolution and the achievement of a representative sampling of the studied batches are currently under investigation. The final objective is the elucidation of parameters to be optimized for the development of a generic approach of homogeneity assessment with hyperspectral imaging.
